Indications
For the long-term treatment of growth failure in children and adolescents with severe primary insulin-like growth factor-1 deficiency (Primary IGFD).
Severe Primary IGFD is defined in the licence approval by several key factors:
- Height standard deviation scores = -3.0 and
- Basal IGF-1 levels below the 2.5th percentile for age and gender and
- GH sufficiency.
- Exclusion of the secondary forms of IGF-1 deficiency, such as malnutrition, hypothyroidism, or chronic treatment with pharmacological doses of anti-inflammatory steroids.
An IGF-1 generation test can be used to confirm diagnosis.
FULL PRESCRIBING INFORMATION
In compliance with the guidelines of the Irish Pharmaceutical Healthcare Association, the self-regulatory body of the pharmaceutical industry in Ireland, the full prescribing information for all of Ipsen's products in Ireland are available now on www.medicines.ie
